Recalls / Generics / Mesalamine
Mesalamine
5 FDA drug recalls involving generic “Mesalamine”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-02-05 | Class II | Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharma | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2024-01-18 | Class II | Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distrib | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2020-10-28 | Class II | Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis La | Teva Pharmaceuticals USA |
| 2020-02-20 | Class II | Mesalamine Delayed-Release Tablets, USP, 1.2 gram, 120-count bottle, Rx Only, Manufactured by: Actavis Laborat | Teva Pharmaceuticals USA |
| 2016-12-02 | Class III | Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US | Shire PLC |